Home page2023-11-13T14:48:46-08:00

Enabling Nucleic
Acid-Based Medicines to Treat Solid Tumor Cancers

Impilo Platform™

The Impilo Platform™ is designed to address key issues that have limited ability of emerging nucleic acid-based therapeutic modalities such as antisense, siRNA, tRNA, and mRNA and in vivo gene editing to effectively treat solid tumor cancers.

Learn More

News and Events

Go to Top